Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BJDX Bluejay Diagnostics	$1.81 -3.7%	$2.57	$1.46 ▼ $316.92	$1.00M	0.4	493,712 shs	75,129 shs
GCTK GlucoTrack	$0.13 +0.4%	$0.18	$0.13 ▼ $62.60	$3.82M	-0.14	2.32 million shs	939,661 shs
HSCS Heart Test Laboratories	$3.96 +2.3%	$3.27	$2.36 ▼ $7.57	$4.28M	2.61	122,431 shs	31,324 shs
NUWE Nuwellis	$0.93 +1.2%	$0.95	$0.75 ▼ $11.66	$4.06M	0.51	972,438 shs	28,370 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BJDX Bluejay Diagnostics	-3.72%	+1.12%	+7.10%	-47.54%	-99.09%
GCTK GlucoTrack	+0.38%	-11.19%	-10.54%	-64.35%	-99.69%
HSCS Heart Test Laboratories	+3.39%	+21.47%	+18.56%	+7.32%	-26.94%
NUWE Nuwellis	+1.20%	-1.35%	+6.54%	-28.62%	-89.15%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BJDX Bluejay Diagnostics	0.0625 of 5 stars	0.0	2.0	0.0	0.0	0.6
GCTK GlucoTrack	0.566 of 5 stars	0.0	3.0	1.1	1.7	0.6
HSCS Heart Test Laboratories	2.3983 of 5 stars	3.5	5.0	0.6	0.0	1.3
NUWE Nuwellis	2.4116 of 5 stars	3.5	5.0	0.6	0.0	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BJDX Bluejay Diagnostics	0.00	N/A	N/A	N/A
GCTK GlucoTrack	0.00	N/A	N/A	N/A
HSCS Heart Test Laboratories	3.00	Buy	$13.00	228.28% Upside
NUWE Nuwellis	3.00	Buy	$17.00	1,731.90% Upside

Current Analyst Ratings Breakdown

Latest BJDX, NUWE, HSCS, and GCTK Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
5/13/2025	NUWE Nuwellis	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
3/18/2025	HSCS Heart Test Laboratories	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$15.00 ➝ $14.00

(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BJDX Bluejay Diagnostics	$250K	4.01	N/A	N/A	$934.50 per share	0.00
GCTK GlucoTrack	N/A	N/A	N/A	N/A	$15.30 per share	N/A
HSCS Heart Test Laboratories	$14.70K	291.21	N/A	N/A	$11.16 per share	0.35
NUWE Nuwellis	$8.79M	0.46	N/A	N/A	$18.40 per share	0.05

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BJDX Bluejay Diagnostics	-$9.95M	-$379.74	N/A	∞	N/A	N/A	-155.67%	-117.82%	N/A
GCTK GlucoTrack	-$7.10M	-$56.60	N/A	∞	N/A	N/A	-826.43%	-707.26%	N/A
HSCS Heart Test Laboratories	-$6.61M	-$7.48	N/A	N/A	N/A	N/A	-117.76%	-84.09%	8/4/2025 (Estimated)
NUWE Nuwellis	-$20.21M	-$18.24	N/A	N/A	N/A	-169.54%	-28,159.25%	-207.24%	8/12/2025 (Estimated)

Latest BJDX, NUWE, HSCS, and GCTK Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/14/2025	Q1 2025	GCTK GlucoTrack	N/A	-$0.34	N/A	-$0.67	N/A	N/A
5/13/2025	Q1 2025	BJDX Bluejay Diagnostics	N/A	-$3.37	N/A	-$3.37	N/A	N/A
5/13/2025	Q1 2025	NUWE Nuwellis	-$0.45	-$0.69	-$0.24	-$0.69	$2.50 million	$1.90 million
3/31/2025	Q4 2024	BJDX Bluejay Diagnostics	-$36.00	-$112.37	-$76.37	-$112.37	N/A	N/A
3/13/2025	Q3 2025	HSCS Heart Test Laboratories	-$2.53	-$2.5722	-$0.0422	-$2.57	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BJDX Bluejay Diagnostics	N/A	N/A	N/A	N/A	N/A
GCTK GlucoTrack	N/A	N/A	N/A	N/A	N/A
HSCS Heart Test Laboratories	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BJDX Bluejay Diagnostics	N/A	6.26	6.26
GCTK GlucoTrack	N/A	0.14	0.14
HSCS Heart Test Laboratories	0.01	1.72	1.52
NUWE Nuwellis	N/A	2.03	1.34

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BJDX Bluejay Diagnostics	18.47%
GCTK GlucoTrack	10.92%
HSCS Heart Test Laboratories	17.24%
NUWE Nuwellis	3.13%

Insider Ownership

Company	Insider Ownership
BJDX Bluejay Diagnostics	0.37%
GCTK GlucoTrack	46.50%
HSCS Heart Test Laboratories	1.80%
NUWE Nuwellis	1.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BJDX Bluejay Diagnostics	9	554,000	551,000	Not Optionable
GCTK GlucoTrack	5	28.64 million	5.57 million	Not Optionable
HSCS Heart Test Laboratories	10	1.08 million	962,000	Not Optionable
NUWE Nuwellis	70	4.37 million	4.26 million	Not Optionable

BJDX, NUWE, HSCS, and GCTK Headlines

Recent News About These Companies

Research Analysts Offer Predictions for Nuwellis Q2 Earnings

May 18, 2025 | americanbankingnews.com

Earnings call transcript: Nuwellis Q1 2025 shows growth in revenue, stock stable

May 14, 2025 | investing.com

Nuwellis Inc (NUWE) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Operational Challenges

May 14, 2025 | finance.yahoo.com

Nuwellis, Inc. (NASDAQ:NUWE) Q1 2025 Earnings Call Transcript

May 14, 2025 | msn.com

Q1 2025 Nuwellis Inc Earnings Call

May 14, 2025 | finance.yahoo.com

Nuwellis, Inc. Partners with KDI Precision Manufacturing to Streamline Operations and Enhance Aquadex Product Manufacturing

May 13, 2025 | nasdaq.com

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 13, 2025 | manilatimes.net

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

May 13, 2025 | seekingalpha.com

Nuwellis, Inc. (NUWE) Reports Q1 Loss, Lags Revenue Estimates

May 13, 2025 | zacks.com

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 13, 2025 | globenewswire.com

Nuwellis, Inc.: Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 13, 2025 | finanznachrichten.de

Nuwellis Q1 Earnings Preview

May 13, 2025 | msn.com

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 12, 2025 | globenewswire.com

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

May 8, 2025 | globenewswire.com

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

April 24, 2025 | globenewswire.com

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

April 22, 2025 | globenewswire.com

Nuwellis, Inc. (NASDAQ:NUWE) Q4 2024 Earnings Call Transcript

March 12, 2025 | msn.com

Nuwellis price target lowered to $13 from $16 at Roth MKM

March 11, 2025 | markets.businessinsider.com

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

March 11, 2025 | seekingalpha.com

Nuwellis, Inc. (NUWE) Reports Q4 Loss, Lags Revenue Estimates

March 11, 2025 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BJDX, NUWE, HSCS, and GCTK Company Descriptions

Bluejay Diagnostics NASDAQ:BJDX

$1.81 -0.07 (-3.72%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$1.84 +0.03 (+1.66%)

As of 05/23/2025 06:02 PM Eastern

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

GlucoTrack NASDAQ:GCTK

$0.13 +0.00 (+0.38%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$0.13 0.00 (-0.23%)

As of 05/23/2025 07:53 PM Eastern

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Heart Test Laboratories NASDAQ:HSCS

$3.96 +0.09 (+2.33%)

Closing price 05/23/2025 03:53 PM Eastern

Extended Trading

$3.92 -0.04 (-1.01%)

As of 05/23/2025 06:52 PM Eastern

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Nuwellis NASDAQ:NUWE

$0.93 +0.01 (+1.20%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$0.96 +0.04 (+3.99%)

As of 05/23/2025 06:50 PM Eastern

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time